Integrity is always doing the right thing for patients, employees, communities, and our stakeholders. It is trusting in what we do, how we do it, and…
In Conversation
The Swiss healthcare law (KVG) outlines three key pillars: benefit, quality and security of supply, and cost affordability. All three are supposed to be considered equally,…
We need to expand the number of therapies that are regularly reimbursed and reduce the reliance on individual approvals. This is a challenge we are actively…
Apart from its strategic location, Mexico is a large market with many competitive advantages
In the past, companies used to conduct separate clinical trials in the US, Europe, and then in China. Now, with simultaneous approvals, Chinese patients can access…
Switzerland’s appeal as a destination for talent is bolstered by factors beyond the industry’s control, like over a century of political stability, a robust legal framework,…
Mexico has all the ingredients necessary to become a global hub for clinical trials—a large population of over 130 million, strong infrastructure, and a highly capable…
We made a strategic decision to move away from being a branded generic company. Instead, we committed to developing and launching new products that offer unique…
I’m deeply committed to helping shape the future of Switzerland’s healthcare system
Here, the entire ecosystem—ranging from biotech startups to global headquarters—has the ingredients for sustained success
Switzerland remains a premier destination for the healthcare, life sciences, and pharmaceutical industries, consistently ranking among the top countries globally in terms of competitiveness
Our commitment is to create a safer, cleaner, and healthier world through innovative solutions and local collaborations
